Bellevue Group AG Increases Holdings in Encompass Health Co. (NYSE:EHC)

Bellevue Group AG lifted its stake in Encompass Health Co. (NYSE:EHC - Free Report) by 38.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 19,233 shares of the company's stock after buying an additional 5,365 shares during the period. Bellevue Group AG's holdings in Encompass Health were worth $1,859,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of EHC. Virtu Financial LLC bought a new stake in Encompass Health in the first quarter valued at approximately $208,000. Cetera Advisors LLC purchased a new stake in shares of Encompass Health in the first quarter worth $291,000. GAMMA Investing LLC boosted its stake in Encompass Health by 92.2% during the 2nd quarter. GAMMA Investing LLC now owns 1,184 shares of the company's stock valued at $102,000 after purchasing an additional 568 shares during the last quarter. Harbor Capital Advisors Inc. raised its holdings in shares of Encompass Health by 275.7% during the second quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company's stock valued at $3,071,000 after purchasing an additional 26,270 shares during the last quarter. Finally, CWM LLC lifted its holdings in shares of Encompass Health by 6.3% during the 2nd quarter. CWM LLC now owns 6,388 shares of the company's stock valued at $548,000 after buying an additional 379 shares during the period. Institutional investors own 97.25% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on EHC shares. KeyCorp boosted their target price on shares of Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a research report on Tuesday, October 29th. Stephens restated an "overweight" rating and set a $105.00 target price on shares of Encompass Health in a research note on Tuesday, August 6th. UBS Group upped their target price on shares of Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, September 25th. Barclays upped their price target on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research note on Tuesday, October 29th. Finally, Truist Financial restated a "buy" rating and set a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Encompass Health has an average rating of "Buy" and an average target price of $107.11.

Encompass Health Trading Up 0.1 %

EHC stock traded up $0.10 during mid-day trading on Friday, reaching $102.94. 273,193 shares of the stock traded hands, compared to its average volume of 629,096. The stock has a market capitalization of $10.37 billion, a PE ratio of 24.86, a PEG ratio of 1.36 and a beta of 0.88. The business has a 50-day moving average price of $98.16 and a two-hundred day moving average price of $91.42. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter last year, the firm posted $0.86 EPS. The firm's revenue was up 11.9% compared to the same quarter last year. Equities research analysts expect that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health's dividend payout ratio (DPR) is 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.